Article
Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis.
European journal of neurology - 1 Jul 2005
Ramsaransing G S M, Heersema D J, De Keyser J
Abstract excerpt
The majority of patients with multiple sclerosis (MS) experience gradual progression of disability, either as secondary progressive MS (SPMS) or primary progressive MS (PPMS). A subgroup with relapsing-remitting MS shows a benign course with little or no disease progression and minimal disability decades after the first manifestations, so called benign MS (BMS). In our search to identify factors that are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
